Alibaba shares fell after U.S. scrutiny of its AI partnership with Apple, compounding recent declines from disappointing earnings. General Motors is lobbying to overturn California's zero-emissions vehicle mandate, citing concerns over market conditions and consumer choice.

CINCINNATI--(BUSINESS WIRE)--Fifth Third (NASDAQ: FITB) today announced a first-of-its-kind initiative to offer free wills to every customer, through an exclusive partnership with Trust & Will, the leading digital estate planning platform in the U.S. Starting today, millions of Fifth Third customers can access a secure, guided online experience to create a state-specific, attorney approved will – at no cost and in less than one hour. This experience is designed to be simple and stress-free,.

HOUSTON--(BUSINESS WIRE)--Phillips 66 today sent a letter to shareholders highlighting the key issues on the ballot at its Annual Meeting on May 21.

SEATTLE--(BUSINESS WIRE)--F5 (NASDAQ: FFIV), the global leader in delivering and securing every app and API, today unveiled F5 BIG-IP Next Cloud-Native Network Functions (CNF) 2.0, an evolved solution that significantly enhances the capabilities of the F5 Application Delivery and Security Platform (ADSP) for large-scale cloud-native applications. With advanced Kubernetes-native features, F5 BIG-IP Next CNF 2.0 redefines how organizations adapt to increasingly complex and resource-intensive oper.

SEATTLE--(BUSINESS WIRE)--F5 (NASDAQ: FFIV), the global leader in delivering and securing every app and API, today announced an expanded collaboration with Red Hat, the world's leading provider of open source solutions, to help enterprises deploy and scale secure, high-performance AI applications. By enabling integration for the F5 Application Delivery and Security Platform with Red Hat OpenShift AI, F5 customers can adopt AI faster and more securely, focusing on practical, high-value use cases.

CHARLOTTE, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2025 Stifel Jaws & Paws Conference. Management is scheduled to present on Wednesday, May 28, 2025, at 9:45 am ET.

DUBLIN and CHICAGO, May 19, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported that Pfizer Inc. (“Pfizer”) has agreed to extend the term for payment of the regulatory milestone payment of $20.0 million until October 25, 2029.

First-in-human study will evaluate safety, tolerability, and early efficacy of a one-time, pancreas-targeted smart GLP-1 TM gene therapy for patients with inadequately controlled T2D and obesity

Diversification is key in REIT investing, mirroring my roulette strategy—spread bets across sectors for optimal risk-adjusted returns. Net lease REITs offer stability and steady dividends, outperforming residential mREITs over 15 years and thriving even in volatile environments. Current market trends and strong earnings support overweighting net lease REITs, with sector consolidation and potential rate cuts as additional tailwinds.

3M has rebounded strongly, gaining 46% in the past year, driven by robust Q1 earnings and a renewed focus on innovation and operational efficiency. Despite legal settlements, I believe 3M remains financially strong, with litigation risks overcompensated in the current undervalued share price. 3M's strategy centers on accelerating product innovation, improving margins, and disciplined capital allocation through dividends and buybacks.

PHOENIX, May 19, 2025 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported first quarter fiscal 2025 financial and operating results.

NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Perpetua Resources Corp. ("Perpetua" or "the Company") (NASDAQ:PPTA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Perpetua securities between April 17, 2024 and February 13, 2025, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or "the Company") (NASDAQ:SANA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Sana securities between March 17, 2023 and November 4, 2024, both dates inclusive (the "Class Period").

Scott Stubbs to Retire as Chief Financial Officer, to be Succeeded by Jeff Norman, Senior Vice President of Capital Markets and Treasury, Effective July 1, 2025 SALT LAKE CITY , May 19, 2025 /PRNewswire/ -- Extra Space Storage Inc. (NYSE:EXR) (the "Company") announced today the planned succession for its Executive Vice President and Chief Financial Officer, P. Scott Stubbs, who will retire on December 31, 2025.

Initiated platform trial of COM701 maintenance therapy in patients with platinum sensitive ovarian cancer in Q2 2025 Recruitment ongoing in the first in human Phase 1 trial of GS-0321 (previously COM503), a potential first-in-class anti-IL18BP antibody licensed to Gilead Partner AstraZeneca expanded their rilvegostomig program to ten Phase 3 trials across lung, gastrointestinal and endometrial cancers and plans to share early data for rilvegostomig at ASCO Solid financial position with cash runway expected to fund operations into 2027 Key leadership transitions to take effect in September 2025 HOLON, Israel , May 19, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: …

NEWTON, Mass. , May 19, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate at the 2025 RBC Capital Markets Global Healthcare Conference in a fireside chat on Wednesday, May 21 at 10:00 a.m.

PHILADELPHIA , May 19, 2025 /PRNewswire/ -- Doral Renewables LLC ("Doral") has successfully closed construction project financing for the Mammoth South, Mammoth Central I, and Mammoth Central II solar projects in Pulaski County, Indiana. The three projects, each with a generation capacity of 300 MWac, are part of the broader 1.3 GW Mammoth Solar facility.

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ultra Clean Holdings, Inc. ("Ultra Clean" or "the Company") (NASDAQ:UCTT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ultra Clean securities between May 6, 2024 and February 24, 2025, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zynex securities between March 13, 2023 and March 11, 2025, both dates inclusive (the "Class Period").

Nuvaxovid™ is the only recombinant protein-based, non-mRNA COVID-19 vaccine available in the U.S. Biologics License Application approval triggers $175 million Sanofi milestone payment, with additional COVID-19 vaccine milestones and ongoing tiered royalties to be recognized when earned GAITHERSBURG, Md. , May 19, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid™ for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adults 65 years and older and individuals 12 through 64 years who have …